426 related articles for article (PubMed ID: 32621644)
1. A double-blind, randomized, placebo-controlled pilot trial of atorvastatin for nephrogenic diabetes insipidus in lithium users.
Fotso Soh J; Beaulieu S; Trepiccione F; Linnaranta O; Torres-Platas G; Platt RW; Renaud S; Su CL; Mucsi I; D'Apolito L; Mulsant BH; Levinson A; Saury S; Müller D; Schaffer A; Dols A; Low N; Cervantes P; Christensen BM; Herrmann N; Rajji T; Rej S
Bipolar Disord; 2021 Feb; 23(1):66-75. PubMed ID: 32621644
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin in the treatment of Lithium-induced nephrogenic diabetes insipidus: the protocol of a randomized controlled trial.
Fotso Soh J; Torres-Platas SG; Beaulieu S; Mantere O; Platt R; Mucsi I; Saury S; Renaud S; Levinson A; Andreazza AC; Mulsant BH; Müller D; Schaffer A; Dols A; Cervantes P; Low NC; Herrmann N; Christensen BM; Trepiccione F; Rajji T; Rej S
BMC Psychiatry; 2018 Jul; 18(1):227. PubMed ID: 30012135
[TBL] [Abstract][Full Text] [Related]
3. Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride.
Bedford JJ; Weggery S; Ellis G; McDonald FJ; Joyce PR; Leader JP; Walker RJ
Clin J Am Soc Nephrol; 2008 Sep; 3(5):1324-31. PubMed ID: 18596116
[TBL] [Abstract][Full Text] [Related]
4. The McGill Geriatric Lithium-Induced Diabetes Insipidus Clinical Study (McGLIDICS).
Rej S; Segal M; Low NC; Mucsi I; Holcroft C; Shulman K; Looper K
Can J Psychiatry; 2014 Jun; 59(6):327-34. PubMed ID: 25007407
[TBL] [Abstract][Full Text] [Related]
5. The effect of atorvastatin on cognition and mood in bipolar disorder and unipolar depression patients: A secondary analysis of a randomized controlled trial.
Fotso Soh J; Almadani A; Beaulieu S; Rajji T; Mulsant BH; Su CL; Renaud S; Mucsi I; Torres-Platas SG; Levinson A; Schaffer A; Dols A; Cervantes P; Low N; Herrmann N; Mantere O; Rej S
J Affect Disord; 2020 Feb; 262():149-154. PubMed ID: 31733459
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of metformin on lithium-induced nephrogenic diabetes insipidus: An experimental study in rats.
Tas HI; Sancak EB
Adv Clin Exp Med; 2021 Nov; 30(11):1185-1193. PubMed ID: 34595852
[TBL] [Abstract][Full Text] [Related]
7. Acetazolamide Attenuates Lithium-Induced Nephrogenic Diabetes Insipidus.
de Groot T; Sinke AP; Kortenoeven ML; Alsady M; Baumgarten R; Devuyst O; Loffing J; Wetzels JF; Deen PM
J Am Soc Nephrol; 2016 Jul; 27(7):2082-91. PubMed ID: 26574046
[TBL] [Abstract][Full Text] [Related]
8. Lithium-induced NDI: acetazolamide reduces polyuria but does not improve urine concentrating ability.
de Groot T; Doornebal J; Christensen BM; Cockx S; Sinke AP; Baumgarten R; Bedford JJ; Walker RJ; Wetzels JFM; Deen PMT
Am J Physiol Renal Physiol; 2017 Sep; 313(3):F669-F676. PubMed ID: 28615247
[TBL] [Abstract][Full Text] [Related]
9. Urine osmolality, cyclic AMP and aquaporin-2 in urine of patients under lithium treatment in response to water loading followed by vasopressin administration.
Wilting I; Baumgarten R; Movig KL; van Laarhoven J; Apperloo AJ; Nolen WA; Heerdink ER; Knoers NV; Egberts AC
Eur J Pharmacol; 2007 Jul; 566(1-3):50-7. PubMed ID: 17466972
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin lowers serum calcium levels in lithium-users: results from a randomized controlled trial.
Soh JF; Bodenstein K; Yu OHY; Linnaranta O; Renaud S; Mahdanian A; Su CL; Mucsi I; Mulsant B; Herrmann N; Rajji T; Beaulieu S; Sekhon H; Rej S
BMC Endocr Disord; 2022 Sep; 22(1):238. PubMed ID: 36153583
[TBL] [Abstract][Full Text] [Related]
11. Atorvastatin does not ameliorate nephrogenic diabetes insipidus induced by lithium or potassium depletion in mice.
Thomsen ML; Grønkjaer C; Iervolino A; Rej S; Trepiccione F; Christensen BM
Physiol Rep; 2021 Nov; 9(21):e15111. PubMed ID: 34762363
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism and severe hypernatremia in a patient with lithium-induced nephrogenic diabetes insipidus and acute kidney injury: a case report.
Goo YJ; Song SH; Kwon OI; Kim M; Suh SH; Oh TR; Choi HS; Bae EH; Ma SK; Kim SW; Kim CS
Ann Palliat Med; 2022 Aug; 11(8):2756-2760. PubMed ID: 34930011
[TBL] [Abstract][Full Text] [Related]
13. Metabolic reprogramming of renal epithelial cells contributes to lithium-induced nephrogenic diabetes insipidus.
Liu M; Deng M; Luo Q; Sun P; Liang A; Li X; Luo X; Pan J; Zhang W; Mo M; Guo X; Dou X; Jia Z
Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166765. PubMed ID: 37245528
[TBL] [Abstract][Full Text] [Related]
14. Genetic deletion of ADP-activated P2Y
Zhang Y; Hansson KM; Liu T; Magnell K; Huang Y; Carlson NG; Kishore BK
Acta Physiol (Oxf); 2019 Feb; 225(2):e13191. PubMed ID: 30257062
[TBL] [Abstract][Full Text] [Related]
15. Secondary oxalosis induced by xylitol concurrent with lithium-induced nephrogenic diabetes insipidus: a case report.
Takayasu S; Kamba A; Yoshida K; Terui K; Watanuki Y; Ishigame N; Mizushiri S; Tomita T; Nakamura K; Yasui-Furukori N; Daimon M
BMC Nephrol; 2020 May; 21(1):157. PubMed ID: 32357847
[TBL] [Abstract][Full Text] [Related]
16. Hydrochlorothiazide attenuates lithium-induced nephrogenic diabetes insipidus independently of the sodium-chloride cotransporter.
Sinke AP; Kortenoeven ML; de Groot T; Baumgarten R; Devuyst O; Wetzels JF; Loffing J; Deen PM
Am J Physiol Renal Physiol; 2014 Mar; 306(5):F525-33. PubMed ID: 24352504
[TBL] [Abstract][Full Text] [Related]
17. Nephrogenic diabetes insipidus in a lethargic lithium-treated patient.
Meinardi JR; Donders SH
Neth J Med; 1997 Mar; 50(3):105-9. PubMed ID: 9121593
[TBL] [Abstract][Full Text] [Related]
18. Successful Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus with Celecoxib: A Promising Therapeutic Option.
Hashikawa R; Yamada H; Fujii T; Ohtsuru S
Am J Case Rep; 2024 Apr; 25():e943244. PubMed ID: 38643357
[TBL] [Abstract][Full Text] [Related]
19. Transient central diabetes insipidus in the setting of underlying chronic nephrogenic diabetes insipidus associated with lithium use.
Posner L; Mokrzycki MH
Am J Nephrol; 1996; 16(4):339-43. PubMed ID: 8739289
[TBL] [Abstract][Full Text] [Related]
20. Cooperative mechanisms of acute antidiuretic response to bendroflumethiazide in rats with lithium-induced nephrogenic diabetes insipidus.
Moosavi SM; Haghani M
Can J Physiol Pharmacol; 2010 Dec; 88(12):1191-201. PubMed ID: 21164566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
